| Jamie Danielle Vander Vorste, PHARMD | |
|
2600 Overlook Ln Nw, Mandan, ND 58554-1594 | |
| (701) 663-5188 | |
| Not Available |
| Full Name | Jamie Danielle Vander Vorste |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 2600 Overlook Ln Nw, Mandan, North Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881180883 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RPH6031 (North Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jamie Danielle Vander Vorste, PHARMD 2600 Overlook Ln Nw, Mandan, ND 58554-1594 Ph: (701) 663-5188 | Jamie Danielle Vander Vorste, PHARMD 2600 Overlook Ln Nw, Mandan, ND 58554-1594 Ph: (701) 663-5188 |
News Archive
As the senatorial campaigns in New Hampshire and Colorado continue to highlight candidate positions on abortion, the rhetoric over the health law calms a bit.
Eribis Pharmaceuticals AB - part of the Karolinska Development portfolio - announced today that it has received follow-on financial investment enabling the company to continue its clinical development program. Based on cardio-protective effects, Eribis' candidate drug has the potential to become an important new therapy for treating acute coronary syndrome (ACS) and reperfusion injury (damage to tissue caused when blood supply returns after a period of ischemia), as well as for surgical preconditioning. The new round of investment from Karolinska Development AB will allow Eribis to strengthen the preclinical material.
A new method for examining the Ebola virus genome could make surveillance quicker and cheaper for West African nations, and help detect new forms of the virus. The detailed procedure is being shared with the research community along with the study paper, which is freely available in the open access journal Genome Biology.
The U.S. District Court for the District of Delaware has rendered a decision in the patent litigation between Alza Corporation, McNeil-PPC, Inc. and Andrx Pharmaceuticals LLC. McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., which markets Concerta (methylphenidate HCI) Extended-Release Tablets CII, said the court held that the patent in suit is not valid or infringed by the filing of Andrx's Abbreviated New Drug Application.
› Verified 7 days ago
Kristen Sperle, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2500 Sunset Drive Nw, Suite 2, Mandan, ND 58554 Phone: 701-214-1868 | |
Cole Darrell Peterson, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 Burlington St Se, Mandan, ND 58554 Phone: 701-667-1843 | |
Tasha Hahka, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2600 Overlook Ln Nw, Mandan, ND 58554 Phone: 701-663-5188 | |
Robyn R Sorensen, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 116 Second Ave Nw, Mandan, ND 58554 Phone: 701-663-1151 Fax: 701-663-4514 | |
H. James Sunderland, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 Burlington St Se, Mandan, ND 58554 Phone: 701-667-1843 Fax: 701-667-4352 | |
Heather Faye Johnson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 Burlington St Se, Mandan, ND 58554 Phone: 701-667-1843 Fax: 701-667-4352 | |
Mccall Zenker, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2807 Plainview Dr Se, Mandan, ND 58554 Phone: 701-290-6441 |